MDT

96.67

+0.59%↑

137.56

-0.2%↓

VEEV

224.65

-0.07%↓

HQY

91.97

-0.76%↓

PHR.US

+0.18%↑

MDT

96.67

+0.59%↑

137.56

-0.2%↓

VEEV

224.65

-0.07%↓

HQY

91.97

-0.76%↓

PHR.US

+0.18%↑

MDT

96.67

+0.59%↑

137.56

-0.2%↓

VEEV

224.65

-0.07%↓

HQY

91.97

-0.76%↓

PHR.US

+0.18%↑

MDT

96.67

+0.59%↑

137.56

-0.2%↓

VEEV

224.65

-0.07%↓

HQY

91.97

-0.76%↓

PHR.US

+0.18%↑

MDT

96.67

+0.59%↑

137.56

-0.2%↓

VEEV

224.65

-0.07%↓

HQY

91.97

-0.76%↓

PHR.US

+0.18%↑

Kodu・Aktsiate loetelu・Myomo Inc

Myomo Inc

Suletud

0.91

Osta Müü

Ülevaade

Aktsiahinna muutus

24h

Praegune

Min

0.9

Max

0.98

Põhinäitajad
By Trading Economics
Sissetulek	969K -3.7M
Müük	438K 10M
Kasumimarginaal	-36.3
Töötajad	184
EBITDA	1.1M -3.1M

Soovitused
By TipRanks
Soovitused	Tugev "osta" hinnang
12 kuu keskmine prognoos	+588.04% upside

Turustatistika
By TradingEconomics
Turukapital	4.6M 37M
Eelmine avamishind	0.91
Eelmine sulgemishind	0.91

Myomo Inc Graafik

Mineviku tootlus ei ole usaldusväärne näitaja tulevaste tulemuste kohta.

Seotud uudised

30. dets 2025, 23:49 UTC

Omandamised, ülevõtmised, äriostud

WiseTech to Sell Expedient to Appease Competition Regulator

30. dets 2025, 17:12 UTC

Suurimad hinnamuutused turgudel

CapsoVision Shares Rise on FDA Application for AI Tool in Swallowable Camera

30. dets 2025, 21:50 UTC

Market Talk

Basic Materials Roundup: Market Talk

30. dets 2025, 21:16 UTC

Omandamised, ülevõtmised, äriostud

Penguin Solutions: Smart Modular to Sell Zilia Stake for $46M

30. dets 2025, 21:08 UTC

Market Talk

U.S. Natural Gas Futures Take Another Wild Ride -- Market Talk

30. dets 2025, 20:41 UTC

Market Talk

Oil Futures Settle Lower in Sluggish Trade -- Market Talk

30. dets 2025, 20:37 UTC

Tulu

The 5 Best Names to Play AI in 2026, According to Wall Street's Loudest Tech Bull -- Barrons.com

30. dets 2025, 19:29 UTC

Market Talk

Corn Extends Pullback in Light Trade -- Market Talk

30. dets 2025, 18:29 UTC

Market Talk

U.S. Oil Rig Count Rises By Three to 412 -- Market Talk

30. dets 2025, 17:20 UTC

Market Talk

Basic Materials Roundup: Market Talk

30. dets 2025, 16:20 UTC

Tulu

Boeing Stock Is on a Roll. Why It Could Gain 25% in the Next Year. -- Barrons.com

30. dets 2025, 16:18 UTC

Omandamised, ülevõtmised, äriostud

Meta Buys AI Startup Manus, Adding Millions of Paying Users -- 2nd Update

30. dets 2025, 16:10 UTC

Market Talk

Eurozone Government Bond Yields Rise, Euro Falls Ahead of Fed Minutes -- Market Talk

30. dets 2025, 15:24 UTC

Market Talk

Australian Dollar Could Rise Versus Sterling -- Market Talk

30. dets 2025, 15:10 UTC

Omandamised, ülevõtmised, äriostud

Meta Stock Rises After Buying Manus. What the China-Founded AI Start-Up Brings. -- Barrons.com

30. dets 2025, 14:24 UTC

Omandamised, ülevõtmised, äriostud

LVMH: The Three Publications Are Challenges, Sciences & Avenir, and La Recherche

30. dets 2025, 14:22 UTC

Omandamised, ülevõtmised, äriostud

LVMH : Szafran Will Serve as Publishing Director For all Three Publications

30. dets 2025, 14:20 UTC

Omandamised, ülevõtmised, äriostud

LVMH: As Part of the Deal, Maurice Szafran Has Been Named President of Les Editions Croque Futur

30. dets 2025, 14:17 UTC

Omandamised, ülevõtmised, äriostud

LVMH: The Deal Also Reflects LVMH's Commitment to Support High-Quality Information and Scientific Culture

30. dets 2025, 14:16 UTC

Omandamised, ülevõtmised, äriostud

LVMH: The Deal Aims to Accelerate the Development and Distribution of the Publications Mainly in Digital Format

30. dets 2025, 14:14 UTC

Omandamised, ülevõtmised, äriostud

LVMH: The Move Includes Three Publications Into UFIPAR Investment Company

30. dets 2025, 14:12 UTC

Omandamised, ülevõtmised, äriostud

LVMH: Les Editions Croque Futur Is a French Publishing House

30. dets 2025, 14:10 UTC

Omandamised, ülevõtmised, äriostud

LVMH Acquires Les Editions Croque Futur

30. dets 2025, 13:49 UTC

Omandamised, ülevõtmised, äriostud

Meta Buys Manus. What the China-Founded AI Start-Up Brings for Zuckerberg. -- Barrons.com

30. dets 2025, 13:36 UTC

Market Talk

U.S. Natural Gas Continues Weather-Driven Rally -- Market Talk

30. dets 2025, 13:30 UTC

Market Talk

Crude Futures Gain in Light Holiday Trade -- Market Talk

30. dets 2025, 12:55 UTC

Market Talk

Triple Flag Precious Metals Offers Opportunity While Mitigating Risk -- Market Talk

30. dets 2025, 11:55 UTC

Market Talk

Tulu

Investors Await Tesco's Profit Outlook Following U.K. Budget Reforms -- Market Talk

30. dets 2025, 11:47 UTC

Tulu

Omandamised, ülevõtmised, äriostud

Meta's Manus Deal Is a Taster of AI Trends for 2026. Watch This Risk. -- Barrons.com

30. dets 2025, 11:35 UTC

Omandamised, ülevõtmised, äriostud

Meta Buys Manus. What the China-Founded AI Start-Up Brings for Zuckerberg. -- Barrons.com

Võrdlus sarnastega

Hinnamuutus

Myomo Inc Prognoos

Hinnasiht

By TipRanks

588.04% tõus

12 kuu keskmine prognoos

Keskmine 6.33 USD 588.04%

Kõrge 10 USD

Madal 4 USD

Põhineb 4 Wall Streeti analüütiku instrumendi Myomo Inc 12 kuu hinnasihil - viimase 3 kuu andmed.

Hinnangu Konsensus

By TipRanks

Tugev "osta" hinnang

4 ratings

Osta

Hoia

Müü

Põhineb 4 analüütiku instrumendi Myomo Inc aktsia reitingul - viimase 3 kuu andmed.

Finantsandmed

Müügi- ja halduskulud

Tegevuskulud

Maksueelne kasum

Müük

Müügikulu

Brutokasum müügist

Intressikulud võla pealt

EBITDA

Ärikasum

Ettevõttest Myomo Inc

Myomo, Inc., a wearable medical robotics company, designs, develops, and produces myoelectric orthotics for people with neuromuscular disorders in the United States, China, Germany, and internationally. The company offers MyoPro, a myoelectric-controlled upper limb brace or orthosis product used for supporting a patient's weak or paralyzed arm to enable and improve functional activities of daily living. It also provides the MyoPro 2, including control technology, configuration software and user interface, and pop-out battery for extended use of the brace; and MyoPro2+ that comprises 3D printed orthotics capability, software enhancements, and a design for donning and doffing of the device. Its products are designed to help improve function in adults and adolescents with neuromuscular conditions due to brachial plexus injury, stroke, traumatic brain injury, spinal cord injury, and other neurological disorders. The company sells its products through various sales channels, including orthotics and prosthetics providers, the Veterans Administration, and its distributors. Myomo, Inc. was incorporated in 2004 and is headquartered in Boston, Massachusetts.